Latest NAV & returns of ICICI PRUDENTIAL ASSET MANAGEMENT COMPANY LTD

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

Add To Compare

NAV on January 20, 2025
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 5,320 cr
Turnover Ratio 49.46%
Expense Ratio 1.08%
Exit Load 1.00%if redeemed within
15 Days
0.00%if redeemed after 15 Days
Returns
  • 1M: -0.99%
  • 1Y: 37.28%
  • 3M: -1.36%
  • 3Y: 24.90%
  • 6M: 15.08%
  • 5Y: 30.21%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Dharmesh Kakkad (Since over 4 years) Sharmila D’mello (Since over 2 years)
ISIN ICICI-GR
Fund Family ICICI Prudential
P/E Ratio 35.26
P/B Ratio 5.20
Launch Date July 12, 2018
Benchmark BSE Healthcare TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs BSE Healthcare TR INR

Alpha 4.86
Beta 0.91
R-Squared 95.17
Info Ratio 1.26
Tracking Err 3.58
Sortino 2.502
Sharpe 1.194
Std Dev 14.950
Risk -
SECTOR WEIGHTINGS (%)
Financial 2.54%
Industrial 0.0%
Technology 0.0%
Basic Materials 0.93%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 96.53%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet

-


Other plans of ICICI Pru Phrm Hlthcare and Dgnstcs PHD


Other Equity funds by ICICI Prudential